Veracyte Inc (NASDAQ: VCYT) on Tuesday, soared 2.05% from the previous trading day, before settling in for the closing price of $33.63. Within the past 52 weeks, VCYT’s price has moved between $18.61 and $33.81.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 34.42% annually for the last half of the decade. The company achieved an average annual earnings per share of 122.13%. With a float of $75.65 million, this company’s outstanding shares have now reached $76.81 million.
In an organization with 815 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 65.56%, operating margin of -8.18%, and the pretax margin is -13.71%.
Veracyte Inc (VCYT) Insider and Institutional Ownership
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Veracyte Inc is 1.52%, while institutional ownership is 103.39%. The most recent insider transaction that took place on Sep 04 ’24, was worth 163,159. In this transaction Chief Commercial Officer-CLIA of this company sold 5,479 shares at a rate of $29.78, taking the stock ownership to the 76,174 shares. Before that another transaction happened on Sep 04 ’24, when Company’s Officer proposed sale 5,479 for $30.29, making the entire transaction worth $165,959.
Veracyte Inc (VCYT) Latest Financial update
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.41 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.15) by -0.26. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 122.13% per share during the next fiscal year.
Veracyte Inc (NASDAQ: VCYT) Trading Performance Indicators
Veracyte Inc (VCYT) is currently performing well based on its current performance indicators. A quick ratio of 4.17 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.60. Likewise, its price to free cash flow for the trailing twelve months is 65.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.74, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 0.41 in one year’s time.
Technical Analysis of Veracyte Inc (VCYT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.87 million. That was better than the volume of 0.76 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 95.25%. Additionally, its Average True Range was 1.29.
During the past 100 days, Veracyte Inc’s (VCYT) raw stochastic average was set at 95.79%, which indicates a significant increase from 89.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.08% in the past 14 days, which was lower than the 59.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.73, while its 200-day Moving Average is $24.38. However, in the short run, Veracyte Inc’s stock first resistance to watch stands at $34.87. Second resistance stands at $35.43. The third major resistance level sits at $35.86. If the price goes on to break the first support level at $33.88, it is likely to go to the next support level at $33.45. The third support level lies at $32.89 if the price breaches the second support level.
Veracyte Inc (NASDAQ: VCYT) Key Stats
Market capitalization of the company is 2.64 billion based on 76,448K outstanding shares. Right now, sales total 361,050 K and income totals -74,400 K. The company made 114,430 K in profit during its latest quarter, and 5,730 K in sales during its previous quarter.
